Skip to main content
Premium Trial:

Request an Annual Quote

ProQinase, Crelux Team on Crystal-Grade Protein Portfolio Offering

NEW YORK (GenomeWeb News) – ProQinase and Crelux have agreed to a partnership to develop and market crystal-grade protein kinases to pharmaceutical and biotechnology customers, the German companies said today.
Under the agreement, ProQinase will produce and exclusively market recombinant protein kinases that are optimized for crystallization, and Crelux will perform quality control for each crystal grade protein batch. Crelux also will continue to provide crystallization and x-ray crystallography services, the firms said.
ProQinase also will grant Crelux privileged direct access to kinase crystal-grade proteins. The companies also will offer new crystal-grade protein or crystal structures tailored for specific customers.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.